FDA Approved: ICATIBANT — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for icatibant (generic icatibant) under ANDA 211021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

SUPPL AP for ICATIBANT (ICATIBANT)